SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,529.07 -242.65
( -0.33%)

Global Indices

Nasdaq

51,510.98 -338.64
(-0.65%)

Dow Jones

7,705.40 -59.01
(-0.76%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.63

14832.09

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.6

Back

Kuber Udyog standalone net profit rises 144.44% in the June 2026 quarter

Jul 24,2026

Net profit of Kuber Udyog rose 144.44% to Rs 0.22 crore in the quarter ended June 2026 as against Rs 0.09 crore during the previous quarter ended June 2025. Sales rose 36.00% to Rs 0.34 crore in the quarter ended June 2026 as against Rs 0.25 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.34	0.25	36
OPM %	85.29	60.00	-
PBDT	0.29	0.09	222
PBT	0.29	0.09	222
NP	0.22	0.09	144

72,529.07 -242.65 ( -0.33%)

51,510.98 -338.64 (-0.65%)

7,705.40 -59.01 (-0.76%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)